Advertisements

Stocking Stuffers

 

iCo Therapeutics Inc. (ICO:CA) Stock Quote

Detailed Quote for iCo Therapeutics Inc. (ICO:CA)
$ 0.075   0.005 (+7.14%) Volume: 114.35k 3:01 PM EST 17-Jan-2020
Today 5d 1m 3m 1y more
Last Price
0.075
Change $
0.005
Change %
7.14%
Tick
  
Bid
0.065
Bid Size
386,000
Ask
0.075
Ask Size
47,000
Open
0.07
High
0.075
Low
0.07
Prev Close
0.07
Last Trade
01/17/20
Volume
114.35k
52 Wk Hi
0.144999995
52 Wk Low
0.05
Market Cap
11.53m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
153,747,713
EPS (TTM)
-0.009999999
PE Ratio
N/A
Exchange
TSXV
News and Media for iCo Therapeutics Inc. (ICO:CA)
Sector News | Topic News
News for iCo Therapeutics Inc. (ICO:CA)
Fri, Jan 10, 2020
8:29 PM iCo Therapeutics Announces Option Grants - Newsfile
Tue, Dec 24, 2019
8:00 AM iCo Therapeutics Announces Completion of Sub-license Transfer and Full Dosing of Fifty Per Cent of Phase 1b Subjects - Newsfile
Wed, Dec 11, 2019
8:46 PM iCo Therapeutics Engages Ora for iCo-008 Ophthalmic Strategy and Pre Phase II FDA Meeting - Newsfile
Mon, Dec 09, 2019
8:00 AM iCo Therapeutics Announces Dosing of First Full Cohort in Second Oral Amphotericin B Study - Newsfile
Mon, Dec 02, 2019
8:00 AM iCo Therapeutics Announces Third Quarter 2019 Financial Results - Newsfile
Mon, Nov 25, 2019
8:00 AM Alexion Pharmaceuticals - iCo's New Partner for the Development and Commercialization of iCo-008 - Newsfile
Mon, Oct 28, 2019
5:00 PM iCo Therapeutics Inc. Provides an Update Regarding Oral Amphotericin Study, Marketing and Partnering Activities - Newsfile
9:15 AM Growth in Monoclonal Antibodies in BioPharma Sector - InvestorIdeas.com
8:00 AM Monoclonal Antibodies; A Growing Sector of the Bio/Pharma Industry and How Smaller Players are Finding a Niche - Newsfile
Tue, Oct 22, 2019
8:04 AM iCo Therapeutics Inc. Provides a Corporate Update - Newsfile
Wed, Aug 28, 2019
5:03 PM iCo Therapeutics Announces Second Quarter 2019 Financial Results - Newsfile
Mon, Aug 19, 2019
8:03 AM iCo Therapeutics Inc. Announces the Issuance of 41,200,000 Units Pursuant to its Non-Brokered Private Placement - Newsfile
Tue, Aug 06, 2019
10:47 PM iCo Therapeutics Provides Corporate Update - Newsfile
Fri, Jun 28, 2019
8:03 AM iCo Therapeutics Announces AGM Voting Results - Newsfile
Thu, May 30, 2019
4:41 PM iCo Therapeutics Announces First Quarter 2019 Financial Results - Newsfile
Tue, Apr 30, 2019
6:39 PM iCo Therapeutics Announces 2018 Year End Financial Results - Newsfile
Tue, Mar 05, 2019
7:26 AM iCo Therapeutics Inc. Announces the Issuance of 3,600,000 Units Pursuant to its Non-Brokered Private Placement - Newsfile
Mon, Feb 25, 2019
8:01 AM iCo Therapeutics Inc. Announces the Issuance of 14,400,000 Units Pursuant to its C$1,250,000 Non-Brokered Private Placement - Newsfile
Tue, Feb 19, 2019
6:01 AM iCo Therapeutics Inc. Announces Upsizing of Non-Brokered Private Placement to $1,250,000 CDN - Newsfile
5:46 AM iCo Therapeutics Inc. Announces Notice of Termination of Sub License for Bertilimumab (iCo-008) - Newsfile
More News for ICO:CA >>

Tags for iCo Therapeutics Inc.

Research stocks or mutual funds related to iCo Therapeutics Inc. by keywords or tags. Find companies that have a similar focus to ICO:CA. The keywords below have been associated to ICO:CA by either user submission or electronic means.

Pharmaceutical and Medicine Manufacturing (325410) Drugs Pharmaceutical and Medicine Industry (3741) Healthcare Common Stock